VIBRACONNECT vs EpiGard Usage & Stats

Most of the 400+ million diabetic patients in the world may be unaware of the looming threat of foot ulcers leading to amputation. High glucose in the blood can lead to neuropathy - damage of nerve cells and loss of sensation, especially on the foot. Hidden injuries are not felt, do not heal, become ulcers, and if untreated lead to gangrene and require amputations - ranging from toe to entire leg. Every 30 seconds, there is one patient who loses his limb because of diabetes. There are an estimated 2 lakh diabetic foot amputations in India every year, leading to disability and further aggravation of the diabetic condition. This can be prevented by early screening for neuropathy. Ayati has come up with VIBRASENSE, a diabetic foot screener on which patients will place the foot and the report will be generated in 50% less time compared to current solutions. VIBRACONNECT application is developed to support VIBRASENSE for generating and sharing the reports. It also enables monitoring the diabetic patients, if they are progressing towards neuropathy. Disclaimer: 1) The usage of the application is restricted to those locations where VIBRASENSE has regulatory clearance. 2) Users to seek a doctor's advice in addition to using this app before making any medical decisions.
  • Apple App Store
  • Free
  • Health & Fitness

Store Rank

- -

Epi Gard is an app which helps to track patient activity for doctors. One and only app which helps doctors to trace their patient's activity.  where also have an option for patient to add there regular medicine and set alarm for it.
  • Apple App Store
  • Free
  • Health & Fitness

Store Rank

- -

VIBRACONNECT vs. EpiGard ranking comparison

Compare VIBRACONNECT ranking trend in the past 28 days vs. EpiGard

Rank

No Data Available

VIBRACONNECT vs. EpiGard ranking by country comparison

Compare VIBRACONNECT ranking trend in the past 28 days vs. EpiGard

No Data to Display

Compare to any site with our free trial

Get started
VIBRACONNECT VS.
EpiGard

December 25, 2024